Literature DB >> 2572813

Carnitine supplementation in pivampicillin treatment.

B Melegh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2572813     DOI： 10.1016/s0140-6736(89)91104-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates.

Authors:  R V Srinivas; B L Robbins; M C Connelly; Y F Gong; N Bischofberger; A Fridland
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

2.  Metabolism of S-1108, a new oral cephem antibiotic, and metabolic profiles of its metabolites in humans.

Authors:  K Totsuka; K Shimizu; M Konishi; S Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

3.  Carnitine status and safety after administration of S-1108, a new oral cephem, to patients.

Authors:  K Shimizu; A Saito; J Shimada; M Ohmichi; Y Hiraga; T Inamatsu; K Shimada; M Tanimura; Y Fujita; T Nishikawa
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.